Suppr超能文献

药物诱导过氧化物酶体和平滑内质网对亚细胞组分中肝酶、辅酶A和长链酰基辅酶A的影响。

Hepatic enzymes, CoASH and long-chain acyl-CoA in subcellular fractions as affected by drugs inducing peroxisomes and smooth endoplasmic reticulum.

作者信息

Berge R K, Aarsland A, Bakke O M, Farstad M

出版信息

Int J Biochem. 1983;15(2):191-204. doi: 10.1016/0020-711x(83)90065-4.

Abstract
  1. The activities of acyl-CoA hydrolase, catalase, urate oxidase and peroxisomal palmitoyl-CoA oxidation as well as the protein content and the level of CoASH and long-chain acyl-CoA were measured in subcellular fractions of liver from rats fed diets containing phenobarbital (0.1% w/w) or clofibrate (0.3% w/w). 2. Whereas phenobarbital administration resulted in increased microsomal protein, the clofibrate-induced increase was almost entirely attributed to the mitochondrial fraction with minor contribution from the light mitochondrial fraction. 3. The specific activity of palmitoyl-CoA hydrolase in the microsomal fraction was only slightly affected while the mitochondrial enzyme was increased to a marked extent (3-4-fold) by clofibrate. 4. Phenobarbital administration mainly enhanced the microsomal palmitoyl-CoA hydrolase. 5. The increased long-chain acyl-CoA and CoASH level observed after clofibrate treatment was mainly associated with the mitochondrial, light mitochondrial and cytosolic fractions, while the slight increase in the levels of these compounds found after phenobarbital feeding was largely of microsomal origin. 6. The findings suggest that there is an intraperoxisomal CoASH and long-chain acyl-CoA pool. 7. The specific activity of palmitoyl-CoA hydrolase, catalase and peroxisomal palmitoyl-CoA oxidation was increased in the lipid-rich floating layer of the cytosol-fraction. 8. The changes distribution of the peroxisomal marker enzymes and microsomal palmitoyl-CoA hydrolase after treatment with hypolipidemic drugs may be related to the origin of peroxisomes.
摘要
  1. 测定了喂食含苯巴比妥(0.1% w/w)或氯贝丁酯(0.3% w/w)日粮的大鼠肝脏亚细胞组分中酰基辅酶A水解酶、过氧化氢酶、尿酸氧化酶和过氧化物酶体棕榈酰辅酶A氧化的活性,以及蛋白质含量、辅酶A和长链酰基辅酶A的水平。2. 给予苯巴比妥导致微粒体蛋白增加,而氯贝丁酯诱导的增加几乎完全归因于线粒体组分,轻线粒体组分贡献较小。3. 氯贝丁酯使微粒体组分中棕榈酰辅酶A水解酶的比活性仅略有影响,而线粒体酶显著增加(3 - 4倍)。4. 给予苯巴比妥主要增强微粒体棕榈酰辅酶A水解酶。5. 氯贝丁酯治疗后观察到的长链酰基辅酶A和辅酶A水平升高主要与线粒体、轻线粒体和胞质组分相关,而苯巴比妥喂养后这些化合物水平的轻微升高主要源于微粒体。6. 研究结果表明过氧化物酶体内存在辅酶A和长链酰基辅酶A池。7. 棕榈酰辅酶A水解酶、过氧化氢酶和过氧化物酶体棕榈酰辅酶A氧化的比活性在富含脂质的胞质组分漂浮层中增加。8. 降血脂药物治疗后过氧化物酶体标记酶和微粒体棕榈酰辅酶A水解酶的变化分布可能与过氧化物酶体的起源有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验